Precivia® simplifies* intravitreal injections by making the procedure faster and more predictable*. Its unique design presents a guide tube accurately oriented to ensure a fixed injection angle of 28°, a fixed distance at 3.5 mm from the limbus, and a controlled depth.
Precivia® ensures a safer injection procedure that eliminates the need of speculum, caliper or pressure plate.
After preparing the patient for the procedure, Precivia® is carefully placed on the patient's eye with the positioning line on the limbus. By gently pushing down and rotating the Precivia® device, the eye is stabilized so the patient feels an anesthetic effect due to the pressure, and cannot see the needle coming. After removing the needle, a rotation post-injection replaces the conjunctiva and seals the injection hole.
Main characteristics:
- Eliminates unnecessary instruments
- Assures accuracy
- Relaxes patients*
- Prevents leakage*
- Compatible with popular anti-VEGF drugs
- Sterile, Single use
- Box of 25
*References: Ratnarajan G, Nath R, Appaswamy S, et al. Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique. British Journal of Ophthalmology 2013;97:395-397. Petri, A., Boysen, K., Cehofski, L.J. et al. Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach. Ophthalmol Ther 9, 191–203 (2020).
¹Registered trade mark of Genentech Inc. ²Registred trade mark of Bayer AG. ¹*Please verify the medical use of Avastin® with your local authorities. Precivia® is a Class Is medical device indicated for intravitreal injections and manufactured by FCI S.A.S. - Notified Body: GMED CE n°0459.
